• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Richard Scheller - Articles and news items

Roche logo

Roche announces phase II clinical results of crenezumab in Alzheimer’s disease

Industry news / 17 July 2014 / Roche

Roche presented data from two phase II studies investigating whether crenezumab can delay cognitive and functional decline in people with mild-to-moderate Alzheimer’s disease…

Roche logo

Roche’s investigational treatment for asthma met its primary endpoint in a phase II study

Industry news, News / 4 August 2011 / Roche

Lebrikizumab has potential to be the first personalized treatment for asthma…

 

Win an Amazon Gift Card worth up to €100!TAKE OUR SURVEY
+ +